Company intelligence / Profile preview
Shandong Kunli Biopharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Shandong Kunli Biopharmaceutical is a Chinese biotechnology company focused on the research, development, production, and sales of biological products, particularly vaccines and therapeutic biologics. The company is well-known for its production of human rabies vaccines and tetanus antitoxins, serving both domestic and international markets. Headquartered in the High-tech Zone of Weifang, Shandong Province, it operates large-scale manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards. Kunli Biopharmaceutical aims to address public health needs through the innovation of preventive vaccines and specialized biological treatments for infectious diseases.
- Therapeutic areas
- Infectious Diseases
- Modalities
- BiologicVaccineRecombinant proteinSmall molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Shandong Kunli Biopharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shandong Kunli Biopharmaceutical.